• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人载脂蛋白(a)的重组kringle IV-10模块:结构、配体结合模式及生物学意义。

Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance.

作者信息

Mochalkin I, Cheng B, Klezovitch O, Scanu A M, Tulinsky A

机构信息

Department of Chemistry, Michigan State University, East Lansing 48824, USA.

出版信息

Biochemistry. 1999 Feb 16;38(7):1990-8. doi: 10.1021/bi9820558.

DOI:10.1021/bi9820558
PMID:10026282
Abstract

The kringle modules of apolipoprotein(a) [apo(a)] of lipoprotein(a) [Lp(a)] are highly homologous with kringle 4 of plasminogen (75-94%) and like the latter are autonomous structural and functional units. Apo(a) contains 14-37 kringle 4 (KIV) repeats distributed into 10 classes (1-10). Lp(a) binds lysine-Sepharose via a lysine binding site (LBS) located in KIV-10 (88% homology with plasminogen K4). However, the W72R substitution that occurs in rhesus monkeys and occasionally in humans leads to impaired lysine binding capacity of KIV-10 and Lp(a). The foregoing has been investigated by determining the structures of KIV-10/M66 (M66 variant) in its unliganded and ligand [epsilon-aminocaproic acid (EACA)] bound modes and the structure of recombinant KIV-10/M66R72 (the W72R mutant). In addition, the EACA liganded structure of a sequence polymorph (M66T in about 42-50% of the human population) was reexamined (KIV-10/T66/EACA). The KIV-10/M66, KIV-10/M66/EACA, and KIV-10/T66/EACA molecular structures are highly isostructural, indicating that the LBS of the kringles is preformed anticipating ligand binding. A displacement of three water molecules from the EACA binding groove and a movement of R35 bringing the guanidinium group close to the carboxylate of EACA to assist R71 in stabilizing the anionic group of the ligand are the only changes accompanying ligand binding. Both EACA structures were in the embedded binding mode utilizing all three binding centers (anionic, hydrophobic, cationic) like plasminogen kringles 1 and 4. The KIV-10/T66/EACA structure determined in this work differs from one previously reported [Mikol, V., Lo Grasso, P. V. and, Boettcher, B. R. (1996) J. Mol. Biol. 256, 751-761], which crystallized in a different crystal system and displayed an unbound binding mode, where only the amino group of EACA interacted with the anionic center of the LBS. The remainder of the ligand extended into solvent perpendicular to the kringle surface, leaving the hydrophobic pocket and the cationic center of the LBS unoccupied. The structure of recombinant KIV-10/M66R72 shows that R72 extends along the ligand binding groove parallel to the expected position of EACA toward the anionic center (D55/D57) and makes a salt bridge with D57. Thus, the R72 side chain mimics ligand binding, and loss of binding ability is the result of steric blockage of the LBS by R72 physically occupying part of the site. The rhesus monkey lysine binding impairment is compared with that of chimpanzee where KIV-10 has been shown to have a D57N mutation instead.

摘要

脂蛋白(a)[Lp(a)]中载脂蛋白(a)[apo(a)]的kringle结构域与纤溶酶原的kringle 4高度同源(75 - 94%),并且与后者一样是自主的结构和功能单位。Apo(a)包含14 - 37个kringle 4 (KIV)重复序列,分为10类(1 - 10)。Lp(a)通过位于KIV - 10中的赖氨酸结合位点(LBS)与赖氨酸 - 琼脂糖结合(KIV - 10与纤溶酶原K4的同源性为88%)。然而,恒河猴中出现且偶尔在人类中出现的W72R替换会导致KIV - 10和Lp(a)的赖氨酸结合能力受损。通过确定KIV - 10/M66( M66变体)在其未结合配体和结合配体[ε - 氨基己酸(EACA)]模式下的结构以及重组KIV - 10/M66R72( W72R突变体)的结构,对上述情况进行了研究。此外,还重新研究了一种序列多态性(约42 - 50%的人群中为M66T)的EACA结合结构(KIV - 10/T66/EACA)。KIV - 10/M66、KIV - 10/M66/EACA和KIV - 10/T66/EACA的分子结构高度同构,表明kringle的LBS在预期配体结合之前就已形成。从EACA结合凹槽中置换出三个水分子以及R35的移动使胍基靠近EACA的羧酸盐以协助R71稳定配体的阴离子基团是配体结合伴随的唯一变化。两种EACA结构均采用嵌入结合模式,利用了所有三个结合中心(阴离子、疏水、阳离子),就像纤溶酶原kringle 1和4一样。本研究中确定的KIV - 10/T66/EACA结构与之前报道的[Mikol, V., Lo Grasso, P. V.和Boettcher, B. R. (1996) J. Mol. Biol. 256, 751 - 761]不同,后者在不同的晶体系统中结晶并显示出未结合的结合模式,其中只有EACA的氨基与LBS的阴离子中心相互作用。配体的其余部分垂直于kringle表面延伸到溶剂中,使LBS的疏水口袋和阳离子中心未被占据。重组KIV - 10/M66R72的结构表明,R72沿着配体结合凹槽平行于EACA的预期位置向阴离子中心(D55/D57)延伸,并与D57形成盐桥。因此,R72侧链模拟配体结合,结合能力的丧失是由于R72物理占据了部分位点而对LBS造成空间位阻的结果。将恒河猴的赖氨酸结合损伤与黑猩猩的进行了比较,在黑猩猩中KIV - 10已被证明存在D57N突变。

相似文献

1
Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance.人载脂蛋白(a)的重组kringle IV-10模块:结构、配体结合模式及生物学意义。
Biochemistry. 1999 Feb 16;38(7):1990-8. doi: 10.1021/bi9820558.
2
Crystal structures of apolipoprotein(a) kringle IV37 free and complexed with 6-aminohexanoic acid and with p-aminomethylbenzoic acid: existence of novel and expected binding modes.载脂蛋白(a)kringle IV37游离状态以及与6-氨基己酸和对氨基甲基苯甲酸结合状态的晶体结构:新型和预期结合模式的存在
J Mol Biol. 1996 Mar 8;256(4):751-61. doi: 10.1006/jmbi.1996.0122.
3
Nuclear magnetic resonance (NMR) solution structure, dynamics, and binding properties of the kringle IV type 8 module of apolipoprotein(a).载脂蛋白(a)的kringle IV型8模块的核磁共振(NMR)溶液结构、动力学及结合特性
Biochemistry. 2007 Feb 20;46(7):1732-42. doi: 10.1021/bi061814g. Epub 2007 Jan 31.
4
Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10.尽管载脂蛋白(a)kringle IV型10中有一个很强的赖氨酸结合位点,但狒狒脂蛋白(a)与赖氨酸琼脂糖和纤维蛋白的结合非常弱。
Biochemistry. 2005 Jan 18;44(2):555-64. doi: 10.1021/bi048156p.
5
Crystal structures of the recombinant kringle 1 domain of human plasminogen in complexes with the ligands epsilon-aminocaproic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic Acid.人纤溶酶原重组kringle 1结构域与配体ε-氨基己酸和反式-4-(氨甲基)环己烷-1-羧酸形成复合物的晶体结构。
Biochemistry. 1996 Feb 27;35(8):2567-76. doi: 10.1021/bi9521351.
6
Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein.人纤溶酶原重组kringle-2结构域与A组链球菌表面蛋白内部肽段的结构及结合决定因素
J Mol Biol. 2001 May 11;308(4):705-19. doi: 10.1006/jmbi.2001.4646.
7
Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57 --> Asn mutation in kringle IV-10 is associated with poor fibrin binding.黑猩猩载脂蛋白(a)羧基末端结构域编码cDNA的分子克隆:kringle IV-10中的Asp57→Asn突变与纤维蛋白结合能力差有关。
Biochemistry. 1998 May 19;37(20):7213-23. doi: 10.1021/bi9721546.
8
Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.载脂蛋白(a)kringle IV-10与纤溶酶原kringle对脂蛋白(a)与调节分子相互作用影响的比较
Thromb Haemost. 1999 Mar;81(3):428-35.
9
Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen.人纤溶酶原重组kringle 5结构域的结构与配体结合决定因素
Biochemistry. 1998 Mar 10;37(10):3258-71. doi: 10.1021/bi972284e.
10
Specificity determinants in the interaction of apolipoprotein(a) kringles with tetranectin and LDL.载脂蛋白(a)kringle结构域与纤连蛋白-4和低密度脂蛋白相互作用中的特异性决定因素
Biol Chem. 2002 Nov;383(11):1743-50. doi: 10.1515/BC.2002.195.

引用本文的文献

1
Lipoprotein(a) and cardiovascular disease.脂蛋白(a)与心血管疾病。
Biochem J. 2024 Oct 2;481(19):1277-1296. doi: 10.1042/BCJ20240037.
2
Fragment-based drug design of novel inhibitors targeting lipoprotein (a) kringle domain KIV-10-mediated cardiovascular disease.基于片段的脂蛋白(a)kringle 结构域 KIV-10 靶向抑制剂的药物设计与心血管疾病
J Bioenerg Biomembr. 2024 Jun;56(3):247-259. doi: 10.1007/s10863-024-10013-2. Epub 2024 Mar 14.
3
Crystal structure of the kringle domain of human receptor tyrosine kinase-like orphan receptor 1 (hROR1).
人受体酪氨酸激酶样孤儿受体 1(hROR1)的kringle 结构域的晶体结构。
Acta Crystallogr F Struct Biol Commun. 2022 May 1;78(Pt 5):185-192. doi: 10.1107/S2053230X22003855. Epub 2022 Apr 22.
4
High resolution structure of human apolipoprotein (a) kringle IV type 2: beyond the lysine binding site.人载脂蛋白(a)kringle IV 型 2 的高分辨率结构:赖氨酸结合位点之外。
J Lipid Res. 2020 Dec;61(12):1687-1696. doi: 10.1194/jlr.RA120001023. Epub 2020 Sep 9.
5
Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain function.鉴定和分析针对载脂蛋白(a)kringle 结构域 KIV-7、KIV-10 和 KV 的抑制剂,可深入了解 kringle 结构域的功能。
J Biol Chem. 2020 Apr 10;295(15):5136-5151. doi: 10.1074/jbc.RA119.011251. Epub 2020 Mar 4.
6
A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors.一项评估 MG1102(载脂蛋白(a) 五聚体结构域 V)在实体瘤患者中的安全性、耐受性和药代动力学的 1 期、开放性、剂量递增研究。
Invest New Drugs. 2017 Dec;35(6):773-781. doi: 10.1007/s10637-017-0460-1. Epub 2017 Mar 28.
7
High-resolution crystal structure of apolipoprotein(a) kringle IV type 7: insights into ligand binding.载脂蛋白(a) kringle IV型7的高分辨率晶体结构:对配体结合的见解。
Protein Sci. 2001 Jun;10(6):1124-9. doi: 10.1110/ps.01701.